Related Experiment Video

Updated: Feb 19, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

7.0K

[Antisense to CDK4 inhibits the growth of human colon cancer cells HT29]

Ying-jiang Ye1, Xue-guang Zhu, Shan Wang

  • 1Surgical Oncology Laboratory, People's Hospital Peking University, Beijing 100044, China.

Zhonghua Yi Xue Za Zhi
|May 10, 2006
PubMed
Abstract

Insights

Antisense CDK4 gene therapy effectively inhibited colorectal cancer cell growth and proliferation. This approach also induced cancer cell apoptosis, offering a potential new treatment strategy for colorectal carcinoma.

Area of Science:

  • Molecular biology
  • Cancer research
  • Gene therapy

Context:

  • Colorectal cancer (CRC) remains a significant global health challenge.
  • Understanding the molecular mechanisms driving CRC proliferation is crucial for developing targeted therapies.
  • Cyclin-dependent kinase 4 (CDK4) plays a key role in cell cycle regulation and is implicated in various cancers.

Purpose:

  • To investigate the therapeutic potential of antisense CDK4 in inhibiting the growth and proliferation of human colorectal cancer cells (HT29).
  • To evaluate the impact of antisense CDK4 transfection on cellular phenotype, cell cycle progression, and apoptosis in HT29 cells.

Summary:

  • HT29 cells were transfected with antisense CDK4 using lipofectamine, with transfection efficiency confirmed by molecular and cellular assays.
  • Transfected cells demonstrated successful expression of antisense CDK4 mRNA, leading to down-regulation of endogenous CDK4 mRNA and protein synthesis.
  • These molecular changes resulted in a partial reversion of the malignant phenotype, inhibition of cell growth and soft agar colony formation, G1 phase arrest, and increased apoptosis.

Impact:

  • Antisense CDK4 effectively suppresses colorectal cancer cell growth and proliferation.
  • The induction of apoptosis by antisense CDK4 presents a promising avenue for gene therapy in colorectal carcinoma.
  • This study provides a foundation for developing novel targeted gene-based treatments for colorectal cancer.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.5K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.6K

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.6K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K